Open AccessDurvalumab and tremelimumab combination therapy versus durvalumab or tremelimumab monotherapy for patients with solid tumors
Author(s) -
Bi-Cheng Wang,
Pengcheng Li,
JinHu Fan,
Guo-He Lin,
Quentin Liu
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000021273
Subject(s) - tremelimumab , durvalumab , medicine , oncology , head and neck squamous cell carcinoma , adverse effect , cancer , immunotherapy , head and neck cancer , nivolumab , ipilimumab